Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-04

Clinical Trial Update: Effects of Abrocitinib Treatment on Skin Barrier Function

View source ↗

Summary

This clinical trial evaluates the effects of abrocitinib on skin barrier function in individuals with atopic dermatitis. The study is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abrocitinib (abrocitinib)

Snippet

Sponsor: Prof. Dr. Stephan Weidinger | Conditions: Atopic Dermatitis | Status: ACTIVE_NOT_RECRUITING